neostigmine has been researched along with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardi, G; Calabresi, P; Centonze, D; Gubellini, P; Pisani, A | 1 |
| Iguchi, A; Suzuki, Y; Umegaki, H; Yamamoto, A | 1 |
| Borsello, T; Calabresi, P; Costa, C; de Iure, A; Di Filippo, M; Ghiglieri, V; Sclip, A; Tantucci, M; Tozzi, A | 1 |
3 other study(ies) available for neostigmine and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
| Article | Year |
|---|---|
Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Acetylcholine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cerebral Cortex; Corpus Striatum; Egtazic Acid; Electric Stimulation; Enzyme Activation; Excitatory Amino Acids; In Vitro Techniques; Male; Microelectrodes; Microinjections; Muscarine; N-Methylaspartate; Neostigmine; Neurons; Protein Kinase C; Rats; Rats, Wistar; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptors, Muscarinic; Synaptic Transmission | 1998 |
Stimulation of the hippocampal glutamate receptor systems induces stress-like responses.
Topics: Acetylcholine; Adrenocorticotropic Hormone; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Behavior, Animal; Blood Glucose; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Excitatory Amino Acid Agents; Hippocampus; Male; Microinjections; N-Methylaspartate; Neostigmine; Rats; Rats, Wistar; Receptors, Glutamate; Stress, Physiological | 2006 |
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease.
Topics: Aging; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cholinesterase Inhibitors; Disease Models, Animal; Hippocampus; Long-Term Potentiation; Mice, Transgenic; Molecular Targeted Therapy; Mutation; N-Methylaspartate; Neostigmine; Plaque, Amyloid | 2015 |